tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Wells says Biktarvy patent settlement ‘big deal’ for Gilead at, $6-$12 upside
PremiumThe FlyWells says Biktarvy patent settlement ‘big deal’ for Gilead at, $6-$12 upside
4d ago
AbbVie sees FY25 adjusted EPS $10.38-$10.58 with IPR&D, milestones expense
Premium
The Fly
AbbVie sees FY25 adjusted EPS $10.38-$10.58 with IPR&D, milestones expense
7d ago
AbbVie sees $1.50 per share unfavorable impact in Q3 from milestones expense
Premium
The Fly
AbbVie sees $1.50 per share unfavorable impact in Q3 from milestones expense
7d ago
AbbVie downgraded to Hold from Buy at HSBC
PremiumThe FlyAbbVie downgraded to Hold from Buy at HSBC
9d ago
Nike reports Q1 beat, U.S. takes 5% stake in Lithium Americas: Morning Buzz
Premium
The Fly
Nike reports Q1 beat, U.S. takes 5% stake in Lithium Americas: Morning Buzz
9d ago
Climb Bio appoints Altschuller as Chief Financial Officer
Premium
The Fly
Climb Bio appoints Altschuller as Chief Financial Officer
9d ago
AbbVie plans to launch ELAHERE in U.K. at list price equal to U.S.
PremiumThe FlyAbbVie plans to launch ELAHERE in U.K. at list price equal to U.S.
11d ago
Video: Drugmakers, Paccar, Wayfair reacting to Trump tariff threats
Premium
The Fly
Video: Drugmakers, Paccar, Wayfair reacting to Trump tariff threats
14d ago
AbbVie submits NDA to FDA for tavapadon for treatment of Parkinson’s disease
Premium
The Fly
AbbVie submits NDA to FDA for tavapadon for treatment of Parkinson’s disease
14d ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100